Quick Takeaways
- Michael Patrick Miller has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $270,524.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Michael Patrick Miller and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| PBYI | PUMA BIOTECHNOLOGY, INC. | Director | $262,515 | -$97,228 | -27% | 11 Nov 2025 |
| RIGL | RIGEL PHARMACEUTICALS INC | Director | $8,009 | 01 Feb 2026 | ||
| BTAI | BioXcel Therapeutics, Inc. | Director | 09 Jan 2026 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|